资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases.

Clin. Chem. Lab. Med.. 2018;

FilippouPanagiota S，RenAnnie H，KorbakisDimitrios，DimitrakopoulosLampros，SoosaipillaiAntoninus，BarakVivian，FrenkelShahar，Pe'erJacob，LotemMichal，MerimsSharon，MolinaRafael，BlasutigIvan，BogdanosDimitrios P，DiamandisEleftheri

Products/Services Used	Details	Operation
Recombinant Proteins	Corresponding supernatants were purified using a Protein G column, according to the manufacturer’s protocol, with binding buffer (20 mM NaH2 PO4 , 150 mM NaCl, pH 8.0) and elution buffer (0.1 M glycine, pH 3.0) (GenScript, Piscataway, NJ, USA).	Get A Quote

摘要

Mucin 13 (MUC13) is a cell surface glycoprotein aberrantly expressed in a variety of epithelial carcinomas. Thus far， the role of MUC13 in various diseases remains elusive. To the best of our knowledge， this is the first study to examine the potential of MUC13 as a serum biomarker in a variety of carcinomas and other conditions.